The current role of digoxin in the treatment of heart failure.
Smith
J R
JR
Division of Cardiology, Northwestern University Medical School, Chicago, IL 60611.
Gheorghiade
M
M
Goldstein
S
S
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D000818:Animals; D002986:Clinical Trials as Topic; D004077:Digoxin / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006333:Heart Failure / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D009490:Neurosecretory Systems / Q000187:drug effects / Q000503:physiopathology; D015996:Survival Rate; D014665:Vasodilator Agents / Q000009:adverse effects / Q000627:therapeutic use
D000806:Angiotensin-Converting Enzyme Inhibitors; D014665:Vasodilator Agents; D004077:Digoxin